SAIC-Frederick

The company will develop the cancer-targeted antibodies for SAIC-Frederick under an NCI proteomics initiative.

The new building will house a wide range of advanced research and development technologies — from biopharmaceutical development and manufacturing to genomics and nanotechnology — that ATPI partners can access by collaborating with NCI.

According to the solicitation, caBIG is seeking a contractor who can "maintain and enhance all components of caB2B in terms of functionality and usability along with maintainability, security, and performance through focused refactoring."

The NCI contractor will use Roche's sequence capture technology and FLX sequencer on cancer genomics tests.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.